Seeking men and women 60 years of age for the study of an investigational vaccine against Respiratory Syncytial Virus
Participants in this trial will be randomly assigned to receive either the investigational vaccine or a placebo (looks like the vaccine, but doesn't contain medication). There will be about 4 clinic visits over 3 years. Visits may include exams, questionnaires, blood draws, nasal swabs, and injections.
What we're hoping for
To determine if the study vaccine, RSVpreF, is safe and effective in preventing RSV infections compared to a placebo.
ClinicalTrials.gov Identifier: NCT05035212